(Q40642496)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

Andreas Evdokiou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Stelios Bouralexis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Fugui Chai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Shelley Hay

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Mark Clayer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

David M Findlay

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

English

0 references

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

491-504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

Osteosarcomas and other cancers of bone

10 December 2019

cites work

1 reference

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

21 January 2018

1 reference

Apoptosis by death factor

21 January 2018

1 reference

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

21 January 2018

1 reference

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

21 January 2018

1 reference

A novel receptor for Apo2L/TRAIL contains a truncated death domain

21 January 2018

1 reference

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

21 January 2018

1 reference

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

21 January 2018

1 reference

Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types

21 January 2018

1 reference

Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells

21 January 2018

1 reference

Cross-talk in cell death signaling

21 January 2018

1 reference

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

21 January 2018

1 reference

Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin

21 January 2018

1 reference

Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells.

21 January 2018

1 reference

Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells.

21 January 2018

1 reference

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

21 January 2018

1 reference

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

21 January 2018

1 reference

Loss of caspase-8 expression in neuroblastoma is related to malignancy and resistance to TRAIL-induced apoptosis.

21 January 2018

1 reference

Inactivation of p53 gene in human and murine osteosarcoma cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11992538%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference